Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-Ranging Study to Evaluate the Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Moderate to Severe Platysmal Bands

NCT04886167 is registered in ClinicalTrials.gov with Clinical Testing of Beverly Hills as lead sponsor.

NCT NCT04886167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04886167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-Ranging Study to Evaluate the Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Moderate to Severe Platysmal Bands
Lead sponsor
Clinical Testing of Beverly Hills
Phase
Phase 1/2
Overall status
Unknown status
Start date
May 30, 2021
Completion date
November 1, 2022
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

platysma bands